TC
Tejara Capital Portfolio holdings
AUM
$216M
This Quarter Return
+0.66%
1 Year Return
-14.3%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$195M
AUM Growth
+$195M
(+14%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
9.92%
Top 10 Holdings %
Top 10 Hldgs %
47.55%
Holding
108
New
13
Increased
36
Reduced
19
Closed
25
Top Buys
| 1 |
Nabors Industries
NBR
|
$9.51M |
| 2 |
Golar LNG
GLNG
|
$8.83M |
| 3 |
CNR
Core Natural Resources, Inc.
CNR
|
$5.52M |
| 4 |
Valaris
VAL
|
$5.46M |
| 5 |
Cameco
CCJ
|
$5.44M |
Top Sells
| 1 |
Scorpio Tankers
STNG
|
$13.9M |
| 2 |
Meta Platforms (Facebook)
META
|
$4.81M |
| 3 |
Tidewater
TDW
|
$4.19M |
| 4 |
Noble Corp
NE
|
$2.95M |
| 5 |
FTAI Aviation
FTAI
|
$2.72M |
Sector Composition
| 1 | Energy | 58.44% |
| 2 | Healthcare | 16.93% |
| 3 | Financials | 7.98% |
| 4 | Industrials | 5.93% |
| 5 | Technology | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Rekor Systems
REKR
$136M
| $734K | 0.38% |
586,829
+177,716
| +43% | +$222K |
|
52
Popular Inc
BPOP
$8.49B
| $683K | 0.35% |
+11,900
| New | +$683K |
|
53
FerroAtlántica
GSM
$778M
| $649K | 0.33% |
131,400
| – | – |
|
|
PTVE
54
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $640K | 0.33% |
+80,000
| New | +$640K |
|
|
SLCA
55
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $616K | 0.32% |
51,605
-15,000
| -23% | -$179K |
|
56
Adeia
ADEA
$1.65B
| $612K | 0.31% |
69,100
+54,100
| +361% | +$479K |
|
57
Arbutus Biopharma
ABUS
$751M
| $606K | 0.31% |
200,000
| – | – |
|
58
Insmed
INSM
$30.1B
| $589K | 0.3% |
34,529
| – | – |
|
|
VAPO
59
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $570K | 0.29% |
865,815
+692,593
| +400% | +$456K |
|
60
Kiniksa Pharmaceuticals
KNSA
$2.61B
| $522K | 0.27% |
+48,500
| New | +$522K |
|
|
CMRX
61
DELISTED
Chimerix, Inc.
CMRX
| $494K | 0.25% |
392,359
+65,527
| +20% | +$82.6K |
|
62
ATAI Life Sciences
ATAI
$971M
| $491K | 0.25% |
271,000
+56,600
| +26% | +$102K |
|
|
CTIC
63
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $462K | 0.24% |
+110,000
| New | +$462K |
|
64
Ocular Therapeutix
OCUL
$2.2B
| $382K | 0.2% |
72,457
-30,000
| -29% | -$158K |
|
65
Clear Channel Outdoor Holdings
CCO
$626M
| $356K | 0.18% |
296,520
-11,900
| -4% | -$14.3K |
|
66
Trevi Therapeutics
TRVI
$883M
| $352K | 0.18% |
190,218
+40,260
| +27% | +$74.5K |
|
|
CELL
67
DELISTED
PhenomeX Inc. Common Stock
CELL
| $339K | 0.17% |
292,379
-20,000
| -6% | -$23.2K |
|
68
Ovid Therapeutics
OVID
$92.4M
| $306K | 0.16% |
118,791
+11,300
| +11% | +$29.2K |
|
|
VINC
69
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $303K | 0.15% |
290,882
-20,000
| -6% | -$20.8K |
|
70
ANI Pharmaceuticals
ANIP
$2.02B
| $302K | 0.15% |
7,600
| – | – |
|
|
MRNS
71
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $267K | 0.14% |
38,649
-57,179
| -60% | -$395K |
|
|
AXDX
72
DELISTED
Accelerate Diagnostics
AXDX
| $254K | 0.13% |
362,631
+100,000
| +38% | +$70K |
|
73
Cullinan Oncology
CGEM
$453M
| $241K | 0.12% |
23,600
| – | – |
|
74
CytomX Therapeutics
CTMX
$341M
| $238K | 0.12% |
157,928
-78,122
| -33% | -$118K |
|
|
FREE
75
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $227K | 0.12% |
88,794
| – | – |
|